Cargando…
Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
The oncogenic activation of AKT gene has emerged as a key determinant of the aggressiveness of colorectal cancer (CRC); hence, research has focused on targeting AKT signaling for the treatment of advanced stages of CRC. In this study, we explored the anti-tumorigenic effects of withaferin A (WA) on...
Autores principales: | Suman, Suman, Das, Trinath P., Sirimulla, Suman, Alatassi, Houda, Ankem, Murali K., Damodaran, Chendil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924683/ https://www.ncbi.nlm.nih.gov/pubmed/26883103 http://dx.doi.org/10.18632/oncotarget.7351 |
Ejemplares similares
-
Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model
por: Suman, Suman, et al.
Publicado: (2016) -
Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer()()
por: Moselhy, Jim, et al.
Publicado: (2017) -
Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer
por: Das, Trinath P., et al.
Publicado: (2016) -
Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis
por: Pal, Deeksha, et al.
Publicado: (2017) -
Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer
por: Das, T P, et al.
Publicado: (2016)